Annual Retained Earnings
-$691.58 M
+$31.87 M+4.41%
December 31, 2024
Summary
- As of March 13, 2025, CTMX annual retained earnings is -$691.58 million, with the most recent change of +$31.87 million (+4.41%) on December 31, 2024.
- During the last 3 years, CTMX annual retained earnings has fallen by -$68.02 million (-10.91%).
- CTMX annual retained earnings is now -1476.03% below its all-time high of -$43.88 million, reached on December 31, 2013.
Performance
CTMX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$691.58 M
+$18.88 M+2.66%
December 31, 2024
Summary
- As of March 13, 2025, CTMX quarterly retained earnings is -$691.58 million, with the most recent change of +$18.88 million (+2.66%) on December 31, 2024.
- Over the past year, CTMX quarterly retained earnings has increased by +$18.88 million (+2.66%).
- CTMX quarterly retained earnings is now -785.07% below its all-time high of -$78.14 million, reached on December 31, 2014.
Performance
CTMX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CTMX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +2.7% |
| 3 y3 years | -10.9% | +4.5% |
| 5 y5 years | -65.8% | +4.5% |
CTMX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.9% | +4.4% | -24.0% | +4.9% |
| 5 y | 5-year | -65.8% | +4.4% | -70.8% | +4.9% |
| alltime | all time | -1476.0% | +4.4% | -785.1% | +4.9% |
CytomX Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$691.58 M(-4.4%) | -$691.58 M(-2.7%) |
| Sep 2024 | - | -$710.46 M(-0.8%) |
| Jun 2024 | - | -$716.19 M(+0.9%) |
| Mar 2024 | - | -$709.66 M(-1.9%) |
| Dec 2023 | -$723.45 M(+0.1%) | -$723.45 M(-0.1%) |
| Sep 2023 | - | -$724.28 M(-0.4%) |
| Jun 2023 | - | -$727.28 M(+0.1%) |
| Mar 2023 | - | -$726.19 M(+0.5%) |
| Dec 2022 | -$722.88 M(+15.9%) | -$722.88 M(+19.5%) |
| Sep 2022 | - | -$605.09 M(+4.0%) |
| Jun 2022 | - | -$581.79 M(+4.3%) |
| Mar 2022 | - | -$557.61 M(-10.6%) |
| Dec 2021 | -$623.56 M(+22.8%) | -$623.56 M(+22.9%) |
| Sep 2021 | - | -$507.50 M(+4.7%) |
| Jun 2021 | - | -$484.91 M(+4.1%) |
| Mar 2021 | - | -$465.67 M(-8.3%) |
| Dec 2020 | -$507.69 M(+21.7%) | -$507.69 M(+16.6%) |
| Sep 2020 | - | -$435.41 M(+3.5%) |
| Jun 2020 | - | -$420.70 M(+3.9%) |
| Mar 2020 | - | -$405.02 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -$417.23 M(+32.5%) | -$417.23 M(+9.3%) |
| Sep 2019 | - | -$381.77 M(+6.6%) |
| Jun 2019 | - | -$358.08 M(+8.8%) |
| Mar 2019 | - | -$329.12 M(+4.5%) |
| Dec 2018 | -$314.98 M(+43.5%) | -$314.98 M(+11.4%) |
| Sep 2018 | - | -$282.75 M(+9.0%) |
| Jun 2018 | - | -$259.32 M(+5.5%) |
| Mar 2018 | - | -$245.87 M(+12.0%) |
| Dec 2017 | -$219.47 M(+24.4%) | -$219.47 M(-0.3%) |
| Sep 2017 | - | -$220.09 M(+4.9%) |
| Jun 2017 | - | -$209.84 M(+13.7%) |
| Mar 2017 | - | -$184.62 M(+4.7%) |
| Dec 2016 | -$176.37 M(+50.1%) | -$176.37 M(+8.6%) |
| Sep 2016 | - | -$162.33 M(+9.9%) |
| Jun 2016 | - | -$147.67 M(+10.6%) |
| Mar 2016 | - | -$133.50 M(+13.6%) |
| Dec 2015 | -$117.47 M(+50.3%) | -$117.47 M(+10.8%) |
| Sep 2015 | - | -$105.98 M(+14.4%) |
| Jun 2015 | - | -$92.61 M(+18.5%) |
| Dec 2014 | -$78.14 M(+78.1%) | -$78.14 M |
| Dec 2013 | -$43.88 M | - |
FAQ
- What is CytomX Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for CytomX Therapeutics?
- What is CytomX Therapeutics annual retained earnings year-on-year change?
- What is CytomX Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly retained earnings year-on-year change?
What is CytomX Therapeutics annual retained earnings?
The current annual retained earnings of CTMX is -$691.58 M
What is the all time high annual retained earnings for CytomX Therapeutics?
CytomX Therapeutics all-time high annual retained earnings is -$43.88 M
What is CytomX Therapeutics annual retained earnings year-on-year change?
Over the past year, CTMX annual retained earnings has changed by +$31.87 M (+4.41%)
What is CytomX Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CTMX is -$691.58 M
What is the all time high quarterly retained earnings for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly retained earnings is -$78.14 M
What is CytomX Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CTMX quarterly retained earnings has changed by +$18.88 M (+2.66%)